World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 113 4834 4534 473 451 725 71909

John D. Hainsworth publications per year

The chart shows the history of publications by John D. Hainsworth between 1957 and 2024, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. John D. Hainsworth published across 68 years, from 1957 to 2024, averaging 11.4 papers a year. Output peaked at 48 publications in 2010. 26 of the 773 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1957 to 2024. Vertical axis: number of publications, 0 to 48. Peak 48 publications in 2010. 1957: 1 publication 1958: 0 publications 1959: 0 publications 1960: 0 publications 1961: 1 publication 1962: 1 publication 1963: 1 publication 1964: 1 publication 1965: 1 publication 1966: 0 publications 1967: 0 publications 1968: 1 publication 1969: 0 publications 1970: 0 publications 1971: 0 publications 1972: 1 publication 1973: 2 publications 1974: 0 publications 1975: 2 publications 1976: 0 publications 1977: 0 publications 1978: 1 publication 1979: 0 publications 1980: 1 publication 1981: 0 publications 1982: 2 publications 1983: 8 publications 1984: 8 publications 1985: 10 publications 1986: 13 publications 1987: 5 publications 1988: 6 publications 1989: 8 publications 1990: 10 publications 1991: 13 publications 1992: 19 publications 1993: 10 publications 1994: 6 publications 1995: 9 publications 1996: 6 publications 1997: 23 publications 1998: 8 publications 1999: 10 publications 2000: 20 publications 2001: 12 publications 2002: 16 publications 2003: 22 publications 2004: 41 publications 2005: 37 publications 2006: 35 publications 2007: 34 publications 2008: 24 publications 2009: 29 publications 2010: 48 publications 2011: 43 publications 2012: 39 publications 2013: 33 publications 2014: 25 publications 2015: 28 publications 2016: 18 publications 2017: 15 publications 2018: 11 publications 2019: 5 publications 2020: 8 publications 2021: 11 publications 2022: 5 publications 2023: 25 publications 2024: 1 publication
1957 2024

773 publications in total across all disciplines

View publications per year as a table
John D. Hainsworth: publications per year, 1957 to 2024
Year Publications
1957 1
1958 0
1959 0
1960 0
1961 1
1962 1
1963 1
1964 1
1965 1
1966 0
1967 0
1968 1
1969 0
1970 0
1971 0
1972 1
1973 2
1974 0
1975 2
1976 0
1977 0
1978 1
1979 0
1980 1
1981 0
1982 2
1983 8
1984 8
1985 10
1986 13
1987 5
1988 6
1989 8
1990 10
1991 13
1992 19
1993 10
1994 6
1995 9
1996 6
1997 23
1998 8
1999 10
2000 20
2001 12
2002 16
2003 22
2004 41
2005 37
2006 35
2007 34
2008 24
2009 29
2010 48
2011 43
2012 39
2013 33
2014 25
2015 28
2016 18
2017 15
2018 11
2019 5
2020 8
2021 11
2022 5
2023 25
2024 1
Total 773
Download as CSV

John D. Hainsworth publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John D. Hainsworth sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 721–740 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 725 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259 725
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

John D. Hainsworth D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Hainsworth sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 112–113 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399 113
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 2014 - Fellow of the American Society of Mechanical Engineers

Overview

John D. Hainsworth is affiliated with the Sarah Cannon Research Institute in the United Kingdom. Their research contributions span multiple areas within medicine, with a focus on oncology and related biomedical sciences.

The fields of study in which Hainsworth has published include Medicine and Biochemistry, Genetics and Molecular Biology. Subfields particularly represented in their work are Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, and Cancer Research.

The main research topics addressed by Hainsworth include:

  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Peptidase Inhibition and Analysis
  • Cancer Immunotherapy and Biomarkers
  • HER2/EGFR in Cancer Research
  • Advanced Breast Cancer Therapies
  • Cancer Genomics and Diagnostics

They have contributed to publications in well-known scientific venues, including:

  • Cancer Research
  • The Lancet Oncology
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Kidney Cancer Journal

Frequent co-authors in their research include Razelle Kurzrock, Howard A. Burris, Funda Meric-Bernstam, Charles Swanton, and Christopher J. Sweeney.

Representative recent papers authored by John D. Hainsworth include:

  • "Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study", 2021, The Lancet Oncology
  • "Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study", 2022, The Lancet Oncology
  • "Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study", 2020, Annals of Oncology
  • "Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study", 2021, Cancer Discovery
  • "Cancer of Unknown Primary in the Molecular Era", 2021, Trends in cancer

John D. Hainsworth was recognized as a Fellow of the American Society of Mechanical Engineers in 2014.

Best Publications

  • BEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCER

    Herbert Hurwitz;Louis Fehrenbacher;William Novotny;Thomas Cartwright

  • Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Howard I. Scher;Karim Fizazi;Fred Saad;Mary-Ellen Taplin

  • Abiraterone and Increased Survival in Metastatic Prostate Cancer

    Johann S. de Bono;Christopher J. Logothetis;Arturo Molina;Karim Fizazi

  • Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

    Aleksandar Sekulic;Michael R. Migden;Anthony E. Oro;Luc Dirix

  • Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

    Marianne E Pavel;John D Hainsworth;Eric Baudin;Marc Peeters

  • Adjuvant docetaxel for node-positive breast cancer.

    Miguel Martin;Tadeusz Pienkowski;John R Mackey;Marek Pawlicki

  • Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

    David F. McDermott;Mahrukh A. Huseni;Michael B. Atkins;Robert J. Motzer

  • Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

    Herbert I. Hurwitz;Louis Fehrenbacher;John D. Hainsworth;William Heim

  • Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study

    Howard S. Hochster;Lowell L. Hart;Ramesh K. Ramanathan;Barrett H. Childs

  • Proposal for classifying the acute emetogenicity of cancer chemotherapy.

    Paul J. Hesketh;Mark G. Kris;Steven M. Grunberg;Thomas Beck

  • Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

    Carla Casulo;Michelle Byrtek;Keith L. Dawson;Xiaolei Zhou

  • Diagnostic and therapeutic management of cancer of an unknown primary

    N. Pavlidis;E. Briasoulis;J. Hainsworth;F.A. Greco

  • Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

    F M Muggia;J D Hainsworth;S Jeffers;P Miller

  • Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

    Frank A. Scappaticci;Louis Fehrenbacher;Thomas Cartwright;John D. Hainsworth

  • Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma

    John D. Hainsworth;Sharlene Litchy;Howard A. Burris;Daniel C. Scullin

  • Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic Adenocarcinoma

    Margaret Tempero;William Plunkett;Veronique Ruiz Van Haperen;John Hainsworth

  • Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

    Roy S Herbst;Rafat Ansari;Frederique Bustin;Patrick Flynn

  • Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

    John D. Hainsworth;Sharlene Litchy;John H. Barton;Gerry Ann Houston

  • Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's Lymphoma—A Randomized Phase II Trial of the Minnie Pearl Cancer Research Network

    John D. Hainsworth;Sharlene Litchy;Don W. Shaffer;Van L. Lackey

  • Targeted therapy for advanced solid tumors on the basis of molecular profiles: Results from mypathway, an open-label, phase IIA multiple basket study

    John D. Hainsworth;Funda Meric-Bernstam;Charles Swanton;Herbert Hurwitz

Frequent Co-Authors

David R. Spigel
David R. Spigel Sarah Cannon Research Institute
F. Anthony Greco
F. Anthony Greco Sarah Cannon Research Institute
Howard A. Burris
Howard A. Burris Sarah Cannon Research Institute
David H. Johnson
David H. Johnson The University of Texas Southwestern Medical Center
Herbert Hurwitz
Herbert Hurwitz Duke University
Walter M. Stadler
Walter M. Stadler University of Chicago
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
Jeffrey R. Infante
Jeffrey R. Infante Janssen (Belgium)
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Charles Swanton
Charles Swanton The Francis Crick Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t have to follow a traditional path. Many students expand their healthcare knowledge with flexible online degrees. For instance, those interested in preventive medicine and wellness can consider a nutrition degree online, which opens doors to roles in dietetics, public health, and health education.

For those focused on healthcare leadership and administration, accredited mha programs deliver essential business and management skills, qualifying graduates for managerial roles in hospitals and health systems.

Registered nurses can advance their careers efficiently through rn bsn online programs no clinicals, allowing working professionals to earn their bachelor’s without disrupting their schedules. Additionally, those seeking advanced clinical or leadership nursing roles may opt for accelerated dnp programs, which provide a fast-track to doctoral-level expertise.

Online healthcare degrees offer diverse pathways for career advancement and specialization—ideal for students at every stage of their medical journey.

Best Scientists Citing John D. Hainsworth

Trending Scientists

Recently Published Articles